Amit Rakhit is President & CMO at Ovid Therapeutics Inc. (OVID). They have made 1 open-market trade across 1 company since 2021, most recently 2021-07-14.
CIK 0001704636
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OVID | 726,823 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2021-07-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OVID | SELL | 2021-07-14 | 2021-07-16 | $3.71 | $252K | +4.1% | +2.5% | -0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.